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Background: Along with the rise in obesity, cardiovascular disease (CVD) has become the major cause of death in
developed countries. Although overt coronary heart disease rarely manifests during childhood, atherosclerosis can
begin by the second decade of life. Therefore, identifying reliable risk markers of early vascular disease in childhood
could be important. Alteration in endothelial function (EF) is an early preclinical marker of the atherosclerotic
process and can be assessed non-invasively using reactive hyperemia peripheral arterial tonometry (RH-PAT). The
purpose of this study was to investigate if obesity in children is associated with lower EF as measured with RH-PAT,
and if obese children with impaired glucose regulation have further impairment in RH-PAT measured EF compared
to obese children with normal glucose tolerance.
Methods: Cardiovascular risk factors, adipocytokines and EF using RH-PAT were evaluated in lean (n = 14) and
obese (n = 37) adolescents (age 12–18 years). Based on an oral glucose tolerance test, the obese group was
subdivided into: obese with normal (NGT, n = 22) and obese with impaired glucose regulation (IGR, n = 15).
Results: RH-PAT score was lower in obese subjects compared to lean controls (1.70 ± 0.02 vs. 1.98 ± 0.09, P = 0.02),
indicating worse EF. This difference remained significant when adjusted for age, sex and ethnicity (P = 0.02). We
observed a pattern of worsening EF with increasing metabolic burden, with RH-PAT scores of 1.98 ± 0.09,1.73 ± 0.08
and 1.65 ± 0.12 in the lean, obese-NGT and obese-IGR groups, respectively, ptrend = 0.03. Obese subjects were more
insulin resistant [higher HOMA] (p = 0.03), and had higher levels of leptin (p = 0.004), hsCRP (p = 0.0004), and TNF-α
(p = 0.03) compared to lean subjects. Adjusting for insulin resistance and adipocytokines substantially attenuated
the obesity association with RH-PAT, suggesting that insulin resistance and inflammation may mediate the
association of EF with obesity.
Conclusions: Risk factors for adult cardiovascular disease, including impaired EF, insulin resistance and
inflammation, are evident in obese adolescents. Whether early detection of these cardiovascular risk factors will be
useful for informing interventions to prevent disease progression needs further study.
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Heart disease is the leading cause of mortality among
adults in the United States. The incidence of heart
disease, especially coronary artery disease, is linked to
increase in obesity in adults. Of concern is that the
prevalence of obesity in adolescents has almost quadru-
pled in the last 30 years, from 5% to 18% [1]. With the
rise in childhood obesity, conditions such as metabolic
syndrome, insulin resistance and type 2 diabetes [2] that
were seen in adults are now increased dramatically in
children. It is predicted that the current generation of
children in the United States, for the first time, will have
shorter life expectancies than their parents [3].
Atherosclerosis is a chronic progressive condition that
may begin as early as childhood and is accelerated in the
presence of defined risk factors, including hypertension,
dyslipidemia and dysglycemia. In the Bogalusa Heart
study, 58% of obese children, aged 5–10 years, had at
least one risk factor for cardiovascular disease and 25%
had two or more [4]. Large scale longitudinal studies
have linked childhood low density lipoprotein (LDL)
cholesterol and body mass index (BMI) to atheroscle-
rosis in adults [5,6]. To decrease cardiovascular disease
in adults it may be useful to establish risk factors and
begin intervention at childhood and adolescence.
Impaired endothelial function is an early marker of
coronary artery disease [7] and has been shown to cor-
relate with traditional metabolic risk factors including
obesity, diabetes and total and/high density lipoprotein
(HDL) cholesterol [8]. Endothelial dysfunction in co-
ronary or peripheral vessels constitutes an independent
predictor of cardiovascular events [9,10]. Given that
early endothelial function changes are reversible, meas-
urement of endothelial function can be used to evaluate
subclinical vascular changes in patients at high risk for
cardiovascular disease at a time when intervention may
be most effective.
Although, non-invasive vascular testing such as carotid
intimal medial thickness and brachial artery ultrasound
are being used in research settings, there are significant
limitations with the use of these technologies in the pe-
diatric population. Reactive hyperemia- peripheral arter-
ial tonometry (RH-PAT) has several potential advantages
over traditional reactive hyperemia measurements. Spe-
cifically, RH-PAT testing is affordable and reproducible;
it is also less operator dependent than assessment of
blood vessel diameter using brachial artery ultrasound.
RH-PAT was recently approved by the Food and Drug
Administration for clinical use in cardio vascular disease
risk stratification in adults. RH-PAT testing which re-
flects small resistance vessel reactivity uses pneumatic
fingertip probes to measure arterial pulse wave ampli-
tude at rest and in response to increased flow, thus pro-
viding a measure of endothelial dependent vasodilation.This technique assesses endothelium-derived nitric oxide
as a vasodilator, as demonstrated in disease free partici-
pants where the administration of agents that block bio-
availability of nitric oxide blunted the RH-PAT response
[11]. In adults, RH-PAT has been shown to correlate
closely with other measures of endothelial function, such
as brachial artery ultrasound, as well as direct measures of
coronary arterial function [12,13]. However brachial artery
ultrasound and RH-PAT are not interchangeable as they
provide different information about distinct aspects of
vascular biology. RH-PAT has been shown to have greater
correlation with glycemic parameters. It was also shown
to better reflect micro vascular impairment in the early
phases of metabolic vascular disease and therefore is ideal
to study young adolescent population [14]. The assess-
ment of arterial endothelial function in obese children has
been done in previous studies using brachial artery ultra-
sound and carotid intimal medial thickening [15-17]
but there is paucity of studies using RH-PAT in pedia-
tric obesity.
The purpose of this study was to investigate if obesity
in children is associated with impaired endothelial func-
tion measured by RH-PAT, and whether such RH-PAT
measured endothelial function differences by obesity may
be mediated by inflammation and insulin resistance. We
also explored whether obese children with hyperglycemia
will have further impairment in endothelial function
compared with obese children having normal glucose
tolerance.
Methods
Study population and ethical considerations
All adolescent participants in the age range of 12–18
years were recruited from the clinics at The Children’s
Hospital at Montefiore located in New York City. Lean
adolescents (BMI 5th-85th percentile) were recruited from
adolescent clinics and obese adolescents (BMI ≥95th per-
centile) were recruited from Endocrinology clinics who
were referred for evaluation of obesity. The clinic popula-
tion was predominantly Hispanic and African American.
All participants were evaluated by the same physician.
Seventy five adolescents were approached, and 61 were
determined to be eligible. Participants were excluded from
the study if there was presence of clinically significant
renal, liver and/or cardiovascular morbidity, diagnosed
inborn error of metabolism and/or endocrine disorders,
including primary dyslipidemia, thyroid disorders, and
genetic syndromes, active or passive smoking, use of fol-
lowing medications: systemic glucocorticoids (those on
inhaled steroids were not excluded), anti-epileptic and
psychiatric medications or use of over-the-counter nut-
ritional supplements (except multivitamins). A total of
51 participants at puberty (Tanner stage 2 or above)
completed the study and except for three participants
Agarwal et al. International Journal of Pediatric Endocrinology 2013, 2013:18 Page 3 of 7
http://www.ijpeonline.com/content/2013/1/18(two Caucasians, one Asian), they were Hispanics (38)
or African Americans (10).
Written informed consent was obtained from the parent
or guardian of each subject and also from the participant.
The protocol was approved by the Albert Einstein College
of Medicine Institutional Review Board (IRB).
Study procedures
All participants completed the same testing regimen.
Participants were instructed to fast from midnight before
the study and advised to avoid caffeine for the preceding
24-hr period. On the morning of testing the participants
presented at the clinical research center for weight,
height, waist and hip circumference measurements. Waist
and hip circumference were measured as per standard
protocol [18]. Both circumferences were measured in the
standing position and at the end of a gentle expiration.
The waist to hip ratio (WHR) was calculated to assess
body fat distribution. Body mass index (BMI) was calcu-
lated using CDC 2000 growth curves [19]. Blood pressure
was measured according to the American Heart Asso-
ciation guidelines [20], using a standard Riva-Rocci
sphygmomanometer with an appropriate size cuff and
a stethoscope. Participants were classified as hypertensive
if their systolic or diastolic blood pressure was higher than
the 95th centile for age after adjustment for height.
Reactive hyperemia- peripheral arterial tonometry tes-
ting (EndoPAT, Itamar Medical, Israel) was conducted as
per standard protocol. Briefly, pulse volume was mea-
sured by a finger plethysmographic device that allows
isolated detection of pulsatile arterial volume changes,
which are sensed by a pressure transducer and trans-
ferred to a computer where the signal is amplified, dis-
played and stored. Studies were performed with the
participant at rest, in a comfortable, thermo-neutral en-
vironment. Fingertip probes were placed on the index
finger of both hands and 5 minutes of baseline recording
were obtained. Blood flow was then occluded in one arm
for 5 minutes, using a standard blood pressure cuff. Re-
cording continues in both fingers during occlusion and
for 5 minutes after release of the cuff. The RH-PAT
index was calculated as the ratio of the average pulse
amplitude in the post-hyperemic phase divided by the
average baseline amplitude, with normalization to the
signal in the control arm to compensate for any systemic
changes. Lower RH-PAT ratios reflect the presence of
impaired endothelial function.
Immediately after RH-PAT testing, a fasting blood
sample was drawn from the non-occluded arm for mea-
surement of glucose, insulin, liver function tests, blood
urea nitrogen, creatinine, lipid profile (total cholesterol,
high density lipoprotein cholesterol, low density lipopro-
tein cholesterol, triglyceride), high sensitive C-Reactive
Protein (hsCRP), leptin, adiponectin, tumor necrosisfactor alpha (TNF-α) and free fatty acids (FFA). In ad-
dition, obese participants underwent an oral glucose tole-
rance test (OGTT) with a glucose load of 1.75 g/kg body
weight. The maximum administered dose of glucose was
75 g. Categorization of glucose tolerance status was made
using American Diabetes Association guidelines [21]. Ho-
meostatic model assessment (HOMA) was calculated for
all participants from glucose and insulin concentrations
obtained in the fasting state [22].
Statistical analysis
Statistical analysis was conducted using STATA version
12 software. Comparisons of cardiovascular risk factors,
adipocytokines, and RH-PAT scores were made between
obese adolescents and healthy lean controls. Continuous
variables that met normality assumptions were expressed
as mean ± SE. Differences in proportions were assessed
using Chi-square test/or Fisher’s exact test as appro-
priate. Cardio metabolic characteristics, RH PAT ratios,
insulin resistance and inflammatory markers in obese
participants and controls were compared using indepen-
dent samples t-tests or Mann–Whitney U tests if nor-
mality assumptions did not hold.
A three level ordered categorical variable was con-
structed representing lean control, obese normal glucose
tolerance (NGT) and obese impaired glucose regulation
(IGR) and trends among these categories were assessed
for cardiovascular risk factors, adipocytokines, and RH-
PAT score using Spearmen rank correlation. Additionally
linear regression models were constructed with RH-PAT
as outcome variable and BMI as a continuous independ-
ent variable unadjusted and adjusted for HOMA, leptin,
hsCRP and TNF-α respectively in separate models. A
two-tailed alpha of 0.05 was used to indicate statistical
significance.
Results
Characteristics of the study participants are shown in
Table 1. There were 37 obese participants and 14 lean
controls. The obese group was further sub-grouped into
those with normal and those with impaired glucose
regulation. ObeseNGT was defined as a fasting glu-
cose level < 100 mg/dl and a 2 hour postprandial
glucose level < 140 mg/dl. Obese IGR was defined as a
fasting level ≥100 mg/dl and/or 2 hr ≥140 mg/dl using
a glucose load of 1.75 g/kg body weight (max 75 g).
Obese NGT, obese IGR and lean control participants
were of similar age, sex and ethnic distribution. There
was a significant trend for BMI and waist circumference
among the three groups going from lean control to
obese IGR (both p < 0.001) (Table 1). There was also a
non-significant trend towards higher triglyceride (p = 0.09)
and lower HDL levels (p = 0.21). There was no significant
trend in systolic or diastolic blood pressure.
Table 1 Clinical and metabolic characteristics of lean and obese adolescents
Characteristic* Lean control (n = 14) Obese P for trend
NGT (n = 22) IGR (n = 15)
AGE (years) 14.93 ± 0.64 15.45 ± 0.0.42 15.26 ± 0.54 0.63
Females 64% 72% 73% 0.85
Race/Ethnicity
Hispanic 71.4% 73% 80% 0.9
AA 21.4% 18% 20%
Others 7% 9% 0%
Weight (Kg) 56.34 ± 2.49 98.42 ± 5.20 101.78 ± 4.86 0.64
WAIST (cm) 75.98 ± 1.86 103.54 ± 3.20 110.45 ± 4.01 <0.001
BMI (kg/m2) 22.69 ± 0.77 36.37 ± 1.89 37.44 ± 1.25 <0.001
SYSBP (mmHg) 117.50 ± 3.31 118.14 ± 2.18 111.53 ± 2.24 0.19
DIASBP (mmHg) 70.71 ± 2.41 68.31 ± 3.86 71.47 ± 2.47 0.99
Fasting Glucose (mg/dl) 86.9 ± 4.00 82.36 ± 1.53 101.33 ± 4.51 0.001
HbA1C (%) 5.55 ± 0.16 5.61 ± 0.09 5.77 ± 0.13 0.39
HOMA-IR 1.75 ± 0.65 4.22 ± 0.56 10.42 ± 0.43 <0.001
TG (mg/dl) 72.50 (53–97) 81 (61–122) 97 (62–164) 0.09
HDL (mg/dl) 50.5 (41–58) 41.5 (37–46) 40 (36–52) 0.21
Legend –AA—Africo-American, SYSBP—systolic BP, DYSBP—diastolic BP, HDL -- high density lipoprotein, TG—triglycerides, HOMA-IR-- homeostatic model
assessment for insulin resistance: {fasting glucose (mg/dl)}{fasting insulin(μU/ml)}/40, NGT- fasting glucose level < 100 mg/dl and a 2 hour postprandial glucose
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Figure 1 RH-PAT score (unadjusted) in lean, obese NGT &
obese IGR subjects.
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Whereas there was no significant difference in HbA1C
(5.62 ± 0.09 vs. 5.77 ± 0.13, p = 0.34) and fasting plasma
glucose values (90.05 ± 2 vs. 86.9 ± 4, p = 0.52) between
the obese and lean control groups, obese subjects were
more insulin resistant [higher HOMA] (6.88 ± 0.9 vs.
1.75 ± 0.65, p = 0.03), compared to lean subjects and
with a significant trend among the three groups (p for
trend < 0.01) (Table 1).
Endothelial function
RH-PAT score was lower in the obese group (1.70 ± 0.02
vs. 1.98 ± 0.09, p = 0.02) compared with lean controls
(p = 0.02), indicating worse endothelial function. This
difference remained significant when adjusted for age,
sex and ethnicity (p = 0.02). We observed a pattern of
worsening endothelial function with increasing meta-
bolic burden, with RH-PAT scores of 1.98 ± 0.09, 1.73 ±
0.08 and 1.65 ± 0.12 in the lean, obese-NGT and obese-
IGR groups, respectively (p for trend =0.03) (Figure 1).
Adipocytokines
Obese participants had higher levels of leptin (33.77 ±
2.7 vs. 18.39 ± 4.5; p = 0.004), hsCRP (4.76 ± 0.76 vs. 0.69 ±
0.24; p = 0.0004), and TNF-α (22.94 ± 4.0 vs. 13.48 ± 1.0;
p = 0.03) compared with lean participants (Table 2). FFA
levels (0.55 ± 0.05 vs. 0.48 ± 0.06; p = 0.38) and adi-
ponectin levels (5.63 ± 0.42 vs 7.53 ± 1.2; p = 0.09) were
similar between obese and control participants. Whenlooked at across the three categories- lean, obese NGT
and obese IGR, there were significant trends for leptin,
hsCRP, TNF-alpha, and a non-significant trend for adi-
ponectin, but no apparent trend for FFA (Table 2).
Associations of BMI with RH-PAT
When adjusted for insulin resistance (HOMA-IR) or adi-
pocytokines (leptin, hsCRP, TNF-α) the β coefficient for
BMI was attenuated in each instance >50%; consistent
with both insulin resistance and inflammation media-
ting the association of BMI with endothelial function
(Table 3). Using Spearman’s correlation, RH-PAT was
inversely correlated with BMI, rho = −0.32 (p = 0.02),
waist circumference, rho = −0.31 (p = 0.03) and HOMA,
rho = −0.32 (p = 0.04).
Table 2 Adipocytokines and RH-PAT score in lean control and obese adolescents with normal and impaired glucose
tolerance test
Adipocytokines Lean control (n = 14) Obese Obese total
(n = 37)
P* P** for trend
Obese NGT (n = 22) Obese IGR (n = 15)
Adiponectin (μg/ml) 7.53 ± 1.17 5.84 ± 0.51 5.17 ± 0.74 5.63 ± 0.42 0.09 0.10
Leptin (ng/ml) 18.39 ± 4.49 34.28 ± 3.41 32.95 ± 4.67 33.77 ± 2.71 0.004 0.02
hsCRP (mg/l) 0.69 ± 0.24 5.21 ± 1.11 4.16 ± 0.98 4.76 ± 0.76 0.0004 0.001
TNF-α (pg/ml) 13.48 ± 1.03 20.07 ± 5.05 27.12 ± 6.69 22.94 ± 4.03 0.03 0.006
FFA (mmol) 0.48 ± 0.06 0.60 ± 0.09 0.50 ± 0.04 0.55 ± 0.05 0.38 0.67
RH-PAT score 1.98 ± 0.09 1.73 ± 0.08 1.65 ± 0.12 1.70 ± 0.06 0.02 0.03
Legend -- CRP -- C-reactive protein, TNF-α—tumor necrosis factor, FFA- free fatty acids, RH-PAT -Peripheral arterial tonometry-hyperemic response. Values are
mean ± SE, p*- lean vs. obese using independent t test, p**- p for trend using spearman correlation.
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In this study, we observed worse endothelial function in
adolescents with obesity compared to healthy lean con-
trols when adjusted for age, sex and ethnicity as mea-
sured by RH-PAT. RH-PAT was inversely correlated with
BMI, waist circumference, and HOMA, and showed a
downward trend among lean control, obese NGT and
obese IGR participants. In addition the association of BMI
with RH-PAT was attenuated when adjusted for HOMA,
leptin, hsCRP or TNF-alpha, consistent with mediation by
these factors. These observations have important clinical
relevance as alteration in endothelial function precedes
anatomical changes of atherosclerosis [9].
Though other non –invasive methods to assess en-
dothelial function using brachial artery ultrasound are
well-established research tools, there are significant limi-
tations to these techniques such as operator-dependency,
technical challenges with the pediatric age group and the
need for substantial training and expertise. RH-PAT offers
a non-invasive method to assess endothelial function cli-
nically in an outpatient setting, and has been shown to
correlate with peripheral artery flow mediated dilatation,
as well as direct measures of coronary artery endothelial
function [23-25]. The findings of the current study sup-
port earlier work [26] that suggests RH-PAT could serve
as a useful tool to identify children and adolescents who
could develop high risk for cardio vascular disease as
adults, and extends that work to a population of inner city
Bronx adolescents.Table 3 Associations of BMI with RHPAT
Model 1 Model 2
BMI −0.02 p = 0.004 −0.009 p = 0.25




Values are linear regression coefficients and p values.
Model 1 unadjusted; Model 2 adjusted for HOMA; Model 3 adjusted for Leptin; ModPrevious studies of early vascular changes in the pe-
diatric population have reported inconsistent findings.
Studies [27-29] in severely obese pre-pubertal children
have failed to show correlations between carotid intimal-
medial thickening with BMI or waist circumference.
Other researchers [15,26] have observed significantly
worse endothelial function and arterial wall stiffness
in obese adolescents compared with lean controls, con-
sistent with the current study results. One can specu-
late that puberty and/or time affects the progression of
these changes. Longitudinal studies beginning in pre-
adolescence and continuing to adulthood may be re-
quired to clarify the sequence of events that leads to
atherosclerosis in children.
Obesity might promote preclinical atherosclerotic
changes via a direct effect on vascular physiology. Obese
children and adolescents are at an increased risk of de-
veloping cardiovascular disease in adulthood [30]. Being
overweight in adolescence has been demonstrated to in-
crease the likelihood of adult all-cause mortality, and
cardiovascular disease morbidity and mortality among
those overweight in adulthood [31]. Our finding of an as-
sociation between leptin, hsCRP, TNF-α and HOMA with
obesity supports the possibility that the increased risk
other researchers have observed might be due to a pro-
longed exposure of arteries to the metabolic milieu [32].
Insulin has direct vasodilatory effect through stimula-
tion of nitric oxide production in endothelial cells via
PI3-K and Akt pathways [14]. In individuals with insulinModel 3 Model 4 Model 5
0.015 p = 0.20 −0.01 p = 0.27 −0.01 p =0.22
−0.01 p = 0.009
0.006 p = 0.76
0.002 p = 0.59
el 4 adjusted for CRP; Model 5 adjusted for TNF-α.
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other effects of insulin mediated via MAP-K pathway in-
cluding stimulation of migration and growth of smooth
muscle cells and production of PAI-1 are intact. There-
fore, individuals with insulin resistance may have abnor-
mality in nitric oxide production by endothelial cells on
the one hand and constant stimulation of pro-atherogenic
changes in the vasculature in response to hyperinsulinism
on the other hand, both increasing the risk of atheros-
clerosis [33].
Vascular inflammation is a key element in the develop-
ment of cardiovascular disease [11]. In our study, obese
adolescents had significantly higher acute-phase reac-
tants and low-grade inflammation, a well-recognized com-
ponent of atherosclerosis. Elevated hsCRP is consistent
with a pro-inflammatory state. In adults it has also been
found to predict the development of cardio vascular
disease [34].
Adipose tissue secretes bioactive peptides called “adi-
pokines” which play a major role in energy and vascular
homeostasis and have been also linked to the pathoge-
nesis of insulin resistance, metabolic syndrome, type 2
diabetes, and atherosclerosis, leading to an increased risk
of cardio vascular disease [35]. Some of the adipokines
analyzed in our study such as TNF-α and leptin were
significantly higher in obese adolescents compared with
lean controls. Elevated values in obese adolescents is
consistent with an underlying low grade inflammation,
as has been noted in other studies in both Hispanic and
non-Hispanic obese children and adolescents [36].
Data from human studies support a direct indepen-
dent pro-atherogenic role of hyperglycemia [37,38]. Our
study found the lowest endothelial function in the sub-
group of obese adolescents with IGR compared with
obese NGT and lean controls, however the difference
within the obese adolescents was less than the difference
of either obese subgroup with normal controls, and we
did not have sufficient statistical power with regard to a
direct comparison between the obese subgroups, although
we did observe statistically significant trends among the
three groups. Postprandial acceleration of oxidative stress
and inflammation has been observed in patients with type
2 diabetes [39] but we found no significant difference in
inflammatory markers in the IGR subgroup. We cannot
tell whether this reflects a true lack of difference in the
population or inadequate statistical power. Larger longitu-
dinal studies in obese adolescents with IGR beginning in
preadolescent years and continuing to adulthood are nee-
ded to understand this association further.
There are some limitations to the current study. The
cross-sectional design of this analysis limits our ability
to infer causal relationships. Although, the RH-PAT re-
sults are not observer dependent, this method may be
influenced by physiological states, such as time of theday, diet, temperature and noise [40]. However our re-
search was performed in the early morning within a 2-h
time frame, with participants in a fasted condition, in a
thermo-neutral environment and at complete rest, there-
by reducing the influence of these confounding factors.
While the relatively small number of study participants
limited our statistical power, the study group is likely
representative of inner city Bronx adolescents routinely
seen at our clinics.
Conclusion
Alteration in endothelial function, insulin resistance and
inflammation, all risk factors for adult cardiovascular
disease are associated with obesity in adolescents. Given
the current state of knowledge, the prognostic signifi-
cance of the observed abnormalities identified in obese
adolescents is not known, but the changes in endothelial
function and the pro-inflammatory state suggest that
early detrimental changes may have already begun. Fur-
ther studies are warranted to investigate if interventions
at these early stages informed by endothelial function
measures could improve long term outcomes.
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